Title
PARK11 and Gut-microbiota in Parkinson’s disease- Is there a link?
Date Issued
01 January 2020
Access level
open access
Resource Type
review
Publisher(s)
Innovare Academics Sciences Pvt. Ltd
Abstract
Parkinson’s disease is a genetically heterogeneous, idiopathic and metacentric neurodegenerative disease of the nervous system characterized by progressive generalized slowing movements like bradykinesia, weakness, tremor, and rigidity, and postural instability in along with Parkinson’s disease has been pondered to be a non-genetic distemper. A different way, features are associated such as sleep dysfunction, loss of smell, mood disorder, constipation, excessive salivation, and excessive periodic limb movements in sleep. Feudatory factors encompass head injury, pesticide exposure, and agriculture background. Results with development and assembling of αsynuclein in the central nervous system in the substantia nigra. A little while back, in North American, Parkinson’s disease is a significant relationship indicated to 39.5cM of chromosome 2 (2q36-37; PARK11) portion on the deep arm. Immune-related disorder, notably Crohn’s and leprosy diseases are also associated with Parkinson’s disease, however around 15% persona with Parkinson’s disease have primary level correlative who has the distemper in the genes including LRRK2, SNCA, last one GBA found as a keek part for sporadic Parkinson’s disease.
Start page
453
End page
456
Volume
7
Issue
1
Language
English
OCDE Knowledge area
Neurología clínica Biología celular, Microbiología
Scopus EID
2-s2.0-85080120422
Source
Journal of Critical Reviews
Sources of information: Directorio de Producción Científica Scopus